IPO Edge hosted a fireside chat on Oct. 2 at Nasdaq MarketSite with Andrew Keys, Co-Founder and Chairman of The Ether Machine (Nasdaq: ETHM). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed availing public market investors to...

CorpGov and  IPO Edge are pleased to provide complete video coverage of the fifth annual Palm Beach CorpGov Forum held on Nov. 5-6, featuring a two-day event with panels, firesides and networking receptions. The event comprised an array of speakers...

By Karen Roman March Biosciences said it appointed Gurpreet Ratra, Ph.D., as Chief Business Officer. Dr. Ratra has more than 25 years of experience in the life science industry including cell and gene therapy, as well as equity research leadership, the...

By Karen Roman Acumen Pharmaceuticals, Inc. (Nasdaq: ABOS) said it is presenting new research at the 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference, being held on December 1-4, 2025, in San Diego, California. Acumen and JCR Pharmaceuticals are...

By Karen Roman ReAlta Life Sciences, Inc. announced the designation of Howard Berman, Ph.D., as Executive Chairman of its Board of Directors, effective immediately. “His proven track record in advancing innovative immunology-based therapies and creating value, positions ReAlta for disciplined growth...

Download the Complete Report Here By Rayk Riechmann How to end a transformative year on a high note: better-than-expected land sales and adjusted EBITDA ahead of company guidance. Alico, Inc. (Nasdaq: ALCO) shows once again how to write a turnaround...

Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com Rayk@capmarketsmedia.com

By Karen Roman Vinson & Elkins said it advised Michael MacDougall, Founder and Managing Partner of Global Sports Capital Partners and its affiliates in its investment in Liga de Fútbol Americano (LFA), México’s premier professional American football league. The company...

By Daniella Parra Sequana Medical said the first implantation of the alfapump in the U.S. at Mount Sinai Hospital received FDA approval for the treatment of recurrent or refractory ascites due to liver cirrhosis. Sequana is working to relieve patients...

By Karen Roman Imviva Biotech said it will present its progress in allogenic cell therapy candidates in two oral presentations and five poster presentations at the 67th American Society of Hematology (ASH) Annual Meeting, to be held on December 6-9,...